Abstract
A convenient synthesis of the cruciferous phytoalexin (S)-(−)-spirobrassinin and its (±)-2′-amino analogues have been achieved. Our synthetic route towards (S)-(−)-spirobrassinin is based on the CrO3-mediated cyclization of chiral 1-(2′,3′,4′,6′-tetra-O-acetyl-ß-D-glucopyranosyl)brassinin and subsequent removal of the chiral auxiliary. (±)-2′-Amino analogues of spirobrassinin and 1-methoxyspirobrassinin were obtained from thioureas in one step in an efficient manner with the aid of CrO3. New synthesized compounds were screened in vitro for antiproliferative/cytotoxic activity against six human cancer cell lines by MTT assay. Amino analogues with CF3 functionality displayed good antiproliferative effect.
Graphic abstract
Similar content being viewed by others
References
Pedras MSC, Yaya EE, Glawischnig E (2011) Nat Prod Rep 28:1381
Pedras MSC, Abdoli A (2017) RSC Adv 7:23633
Takasugi M, Monde K, Katsui N, Shirata A (1987) Chem Lett:1631
Gross D, Porzel A, Schmidt J (1994) Z Naturforsch C Biosci 49:281
Monde K, Takasugi M, Shirata A (1995) Phytochemistry 39:581
Storck M, Sacristan MD (1995) Z Naturforsch 50c:15
Mezencev R, Galizzi M, Kutschy P, Docampo R (2009) Exp Parasitol 122:66
Kristofikova Z, Gazova Z, Siposova K, Bartos A, Ricny J, Kotoucova J, Sirova J, Ripova D (2014) Neurochem Res 39:1502
Mehta RG, Liu J, Constantinou A, Hawthorne M, Pezzuto JM, Moon RC, Moriarty RM (1994) Anticancer Res 14:1209
Mezencev R, Mojžiš J, Pilátová M, Kutschy P, Čurillová Z (2004) Int J Canc Prev 1:105
Pilátová M, Šarišský M, Kutschy P, Miroššay A, Mezencev R, Čurillová Z, Suchý M, Monde K, Miroššay L, Mojžiš J (2005) Leukemia Res 29:415
Mezencev R, Mojžiš J, Pilátová M, Kutschy P, Čurillová Z (2007) Effects of phytoalexins on the growth of cancer cells. In: Columbus F (ed) Trends in cancer prevention research. Nova Science Publishers, New York, p 81
Banerjee T, Duhadaway JB, Gaspari P, Sutanto-Ward E, Munn DH, Mellor AL, Malachowski WP, Prendergast GC, Muller AJ (2008) Oncogene 27:2851
Izutani Y, Yogosawa S, Sowa Y, Sakai T (2012) Int J Oncol 40:816
Kim SM, Oh EY, Lee JH, Nam D, Lee SG, Lee J, Kim SH, Shim BS, Ahn KS (2015) Phytother Res 29:1828
Kello M, Drutovic D, Chripková M, Pilatová M, Budovská M, Kuliková L, Urdzík P, Mojžiš J (2014) Molecules 19:10877
Chripkova M, Zigo F, Mojzis J (2016) Molecules 21:1626
Mezencev R, Kutschy P, Salayova A, Curillova Z, Mojzis J, Pilatova M, McDonald J (2008) Chemotherapy 54:372
Kutschy P, Salayová A, Čurillová Z, Kožár T, Mezencev R, Mojžiš J, Pilátová M, Balentová E, Pazdera P, Sabol M, Zburová M (2009) Bioorg Med Chem 17:3698
Budovská M, Pilatová M, Varinská L, Mojžiš J, Mezencev R (2013) Bioorg Med Chem 21:6623
Chripkova M, Drutovic D, Pilatova M, Mikes J, Budovska M, Vaskova J, Broggini M, Mirossay L, Mojzis J (2014) Toxicol In Vitro 28:909
Tischlerová V, Kello M, Budovská M, Mojžiš J (2017) World J Gastroenterol 23:4341
Budovská M, Baláž M, Mezencev R, Tischlerová V, Zigová M, Mojžiš J (2018) J Fluorine Chem 216:24
Suchý M, Kutschy P, Monde K, Goto H, Harada N, Takasugi M, Dzurilla M, Balentová E (2001) J Org Chem 66:3940
Budovská M, Kutschy P, Kožár T, Gondová T, Petrovaj J (2013) Tetrahedron 69:1092
Kutschy P, Suchý M, Monde K, Harada N, Marušková R, Čurillová Z, Dzurilla M, Miklošová M, Mezencev R, Mojžiš J (2002) Tetrahedron Lett 43:9489
Čurillová Z, Kutschy P, Budovská M, Nakahashi A, Monde K (2007) Tetrahedron Lett 48:8200
Budovská M (2014) RSC Adv 4:5575
Pedras MSC, Suchý M, Ahiahonu PWK (2006) Org Biomol Chem 4:691
Budovská M, Tischlerová V, Mojžiš J, Harvanová M, Kozlov O, Gondová T, Tomášková N (2017) Tetrahedron 73:6356
Kutschy P, Sabol M, Marušková R, Čurillová Z, Dzurilla M, Géci I, Alföldi J, Kováčik V (2004) Collect Czech Chem Commun 69:850
Mosmann T (1983) J Immunol Methods 65:55
Kutschy P, Dzurilla M, Takasugi M, Török M, Achbergerová I, Homzová R, Rácová M (1998) Tetrahedron 54:3549
Defilippi P, van Hinsbergh VWM, Bertolotto A, Rossino P, Sileng L, Tarone G (1991) J Cell Biol 114:855
van Hinsbergh VW, Sprengers ED, Kooistra T (1987) Thromb Haemost 57:148
Kaspers GJ, Veerman AJ, Pieters R, Broekema GJ, Huijsmans DR, Kazemier KM, Loonen AH, Rottier MA, van Zantwijk CH, Hählen K (1994) Br J Cancer 70:1047
Acknowledgments
The present study was supported in part by the Grant Agency of Ministry of the Education, Science, Research and Sport of the Slovak Republic (VEGA 1/0753/17 and VEGA 1/0018/16), and the Slovak Research and Development Agency under the Contract No. APVV-16-0446. Moreover, this publication is the result of the project implementation: „Medicínsky univerzitný vedecký park v Košiciach (MediPark, Košice - Fáza II.)“, kód ITMS2014+313011D103 supported by the Operational Programme Research & Innovation, funded by the ERDF“. The authors thank Assoc. prof. D. Berkeš and Dr. J. Markus for synthesis and providing of the (R)-2-(1H-indol-3-yl)glycine.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Budovská, M., Tischlerová, V., Mojžiš, J. et al. An alternative approach to the synthesis of anticancer molecule spirobrassinin and its 2′-amino analogues. Monatsh Chem 151, 63–77 (2020). https://doi.org/10.1007/s00706-019-02528-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-019-02528-x